BUDZ WEED, INC.
WEED, INC. (BUDZ) news
WEED, INC. is a public biotech or pharmaceutical company listed on OTC under the ticker BUDZ, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest WEED, INC. news
We have not published a story on WEED, INC. yet. When there is news, it will appear here.
WEED, INC. annual financials
Questions about WEED, INC.
What is the ticker symbol of WEED, INC.?
WEED, INC. trades under the ticker BUDZ on OTC.
Where is WEED, INC. listed?
WEED, INC. is listed on OTC.
Which country or territory is WEED, INC. listed under?
Our directory records WEED, INC. under United States.
Does aibio.space cover WEED, INC.?
aibio.space lists WEED, INC. among 2,820 public biotech companies and publishes its news here as stories appear.
What was WEED, INC.'s revenue last year?
$0 for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is WEED, INC. profitable?
WEED, INC. reported a net loss of $1.4 million for the fiscal year ended Dec 31, 2025, and used $195,136 of cash in operations, per its annual report to the SEC.
How much cash does WEED, INC. have?
$1,066 in cash at Jun 30, 2026, per its 10-Q.
Investor discussion: WEED, INC.
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- WEED, INC.
- Ticker
- BUDZ
- Listing
- OTC
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio